Association between LXR-α and ABCA1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus in a Chinese Han Population

Author:

Liu Peng1ORCID,Ma Liang2,Zhao Hailing3,Shen Zhengri1,Zhou Xuefeng3,Yan Meihua3,Zhao Tingting3,Zhang Haojun3,Qiu Xinping1,Li Ping3ORCID

Affiliation:

1. Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing, China

2. Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China

3. Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Science, China-Japan Friendship Hospital, Beijing, China

Abstract

We designed a case-control study and selected LXR-α rs7120118 C>T and ABCA1 rs2230806 A>G polymorphisms to determine the correlation between these polymorphisms and diabetic kidney disease (DKD) susceptibility in a Chinese Han population. Three hundred DKD patients and 346 type 2 diabetes mellitus (DM) patients without kidney disease were recruited. Our results showed that rs7120118 was associated with DKD (genotype, P = .027 ; allele, P < .011 ). rs7120118 was associated with a higher risk of DKD under a dominant model adjustment by age and sex ( P = .015 ) and an additive model ( P = .040 ); rs2230806 was associated with a higher risk of DKD under an recessive model ( P < .03 ); the combined effect of rs7120118 CC+rs2230806 GG genotype showed an association of DKD adjustment for age and sex ( P = .009 ). In subgroup analysis of patients without hypercholesterolemia, the rs2230806 genotype frequencies were different between the two groups ( P = .042 ). rs2230806 was associated with increased risk of DKD under a recessive model adjustment for age and sex ( P = .013 ) and an additive model ( P = .031 ). Our results suggest that LXR-α rs7120118 is significantly associated with a higher risk of DKD, and ABCA1 rs2230806 is significantly associated with a higher risk of DKD without hypercholesterolemia in Chinese Han individuals.

Funder

biomedical transformation project of China-Japan Friendship Hospital

Publisher

Hindawi Limited

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3